Gastrointestinal symptoms are seen in patients with COVID-19. The prevalence could be as high as 50%.
Precise identification of paediatric allergy triggers for improved patient management.
Phlebotomy services at home will help patients with diabetes who are considered to be one of the most vulnerable to infection and disease.